PHARMACOLOG I UPPSALA AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1 SEK | +6.84% |
|
+9.89% | +76.68% |
| Apr. 24 | Perpetua Medical AB Appoints Camilla Lonn as CFO | CI |
| Apr. 23 | Pharmacolog i Uppsala AB will Change its Ticker to PERP B from PHLOG B | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 10.11M 933K | Sales 2023 | 9.94M 916K | Capitalization | 3.75M 346K |
|---|---|---|---|---|---|
| Net income 2022 | -19M -1.75M | Net income 2023 | -18M -1.66M | EV / Sales 2022 | 3.67 x |
| Net cash position 2022 | 10.3M 950K | Net cash position 2023 | 5.48M 505K | EV / Sales 2023 | -0.17 x |
| P/E ratio 2022 |
-2.09
x | P/E ratio 2023 |
-0.13
x | Employees | 10 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 49.1% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +6.84% | ||
| 1 week | +9.89% | ||
| Current month | +10.62% | ||
| 1 month | -3.85% | ||
| 3 months | +17.65% | ||
| 6 months | +143.90% | ||
| Current year | +76.68% |
1 week
0.08
0.11
1 month
0.070.12
Current year
0.040.18
1 year
0.021.44
3 years
0.0212.50
5 years
0.0214.50
10 years
0.0244.20
| Managers | Title | Age | Since |
|---|---|---|---|
Hans Erik Dahlin
FOU | Founder | 79 | 07-01-14 |
LiseLotte Söder
DFI | Director of Finance/CFO | 60 | 20-12-31 |
| Chairman | 76 | 16-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 76 | 16-12-31 | |
Hans Erik Dahlin
FOU | Founder | 79 | 07-01-14 |
Ragnar Linder
BRD | Director/Board Member | 71 | 18-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-10 | 0.1 | +6.84% | 658,740 |
| 24-05-08 | 0.0936 | +5.17% | 42,159 |
| 24-05-07 | 0.089 | -7.29% | 23,670 |
| 24-05-06 | 0.096 | +5.49% | 106,251 |
| 24-05-03 | 0.091 | +9.38% | 472,512 |
Delayed Quote Nasdaq Stockholm, May 10, 2024 at 10:27 am EDT
More quotes
Perpetua Medical AB (publ), formerly Pharmacolog I Uppsala AB (publ), is a Sweden-based medical technology company that develops systems and solutions which aim to optimize and ensure correct and effective treatment with injectable drugs. The Company provides solutions and products that verifies that drugs and narcotics used in surgery have not been tampered with, its solutions make a vital contribution to preventing drug diversion. Its products Pharmacolog Dashboard offers a variety of valuable tools, generating reports and statistical analyses of validated pharmaceuticals. Another product WasteLog is a device that manages the workflow by instantly analyzing the waste and returns of injectable controlled substances.
Calendar
2024-08-28
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +76.68% | 1M | |
| -16.33% | 18.62B | |
| +22.02% | 1.94B | |
| +0.39% | 1.68B | |
| +27.15% | 1.26B | |
| -10.70% | 1.03B | |
| -18.27% | 938M | |
| +0.66% | 783M | |
| -25.07% | 628M | |
| +14.62% | 535M |
- Stock Market
- Equities
- PERP B Stock
